Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-09

Clinical Trial Update: A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty [Phase 2]

View source ↗

Summary

Phase 2b study of DU-176b for prevention of venous thromboembolism after total hip arthroplasty has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DU-176b

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Venous Thromboembolism, Thromboembolism | Phase 2 | Status: COMPLETED | Results posted: 2015-02-09